| |
|
|
|
ENDRA Life Sciences Inc.  
|
|
1.07 -0.09 (-0.08%) |
05-23 16:00 |
|
Open: |
1.115 |
Pre close: |
1.16 |
Target:
|
1.61 
|
|
High: |
1.16 |
Low: |
1.021 |
Resistance:
|
1.38
1.62
|
|
Volume: |
81,751 |
Market Cap: |
8M |
Support:
|
1.00
0.83
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.16
|
MACD |
MACD(12,26):
|
-0.15 |
|
MA(20): |
1.36 |
Signal(12,26,9): |
-0.14 |
|
MA(100): |
1.84 |
Stochastic Oscillator |
%K(14,3):
|
25.18 |
|
MA(250): |
2.43 |
%D(3): |
29.83 |
|
Average Volume(K) |
3-Month: |
36091
|
52-Week |
High:
|
5.75 |
|
10-Days: |
16026 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
29.75 |
Change(%): |
-42.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-170.0 |
Shares Out. (M) |
7.42 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-146.8 |
Shares Float (M) |
7.18 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.10 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
19.90 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.330 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.80 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-7.79 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.50 |
P/CF |
-1.02 |
|
|
|
|
|
|
